- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Resonance Technology prepares fMRI product
MR peripherals maker Resonance Technology introduced at the RSNA meeting its new FuncLAB functional MRI system with automated image data processing. FuncLAB presents functional imaging tasks using high-quality 3D graphics and audio with an automated data processing component that eliminates complex, time-intensive manual data analysis. The server for processing fMRI data attaches to the department network. Functional and anatomic images are automatically sent in DICOM format from the scanner to the processor. Resulting brain maps of anatomy fused with functional results are available onsite and over the Web through a browser-based interface.
MR peripherals maker Resonance Technology introduced at the RSNA meeting its new FuncLAB functional MRI system with automated image data processing. FuncLAB presents functional imaging tasks using high-quality 3D graphics and audio with an automated data processing component that eliminates complex, time-intensive manual data analysis. The server for processing fMRI data attaches to the department network. Functional and anatomic images are automatically sent in DICOM format from the scanner to the processor. Resulting brain maps of anatomy fused with functional results are available onsite and over the Web through a browser-based interface.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
